Study of the structure and microflora of urethral tissues in urethral pain syndrome


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Urethral pain syndrome (UPS) is characterized by the occurrence of persistent or recurrent pain in the urethra in the absence of a confirmed infection and other obvious local pathological changes. The study of its pathogenetic aspects is important first of all for understanding the causes of the disease, to prescribe effective treatment, specific recommendations for the prevention and treatment of this disease are also absent. This paper presents the advanced experience of our research group on the study of the urethral state by the in vivo cross-polarization optical coherence tomography (CP OCT) method, and also the results of the microbiota analysis in the urethral tissues. The purpose of the study is to search for the risk factors for UPS and the character of changes in the urethral tissues, using the data of: 1) concomitant pathology, 2) structural changes in the urethral wall in UPS in comparison with chronic cystitis of bacterial etiology 3) studying the microbiota of urethral tissues. Materials and methods: The condition of the urethra was studied in 109 patients: 55 of them with UPS (group «OTS»), without clinical manifestations of inflammation; 41 - with chronic inflammation of the lower urinary tract of various origins (group «Inf»); in 14 patients with stones of the upper urinary tract without pyelonephritis, the urethra was taken as the norm (group «N»). All performed a clinical minimum of studies, also cystoscopy with the study of the bladder triangle, the neck of the bladder and the urethra by the method of in vivo tissue imaging - CP OCT. The device «OCT-1300U» with wavelength of 1300 nm is used. To determine the possible role of UPS disease background, the analysis of concomitant pathology preceding the development of UPS was performed. To analyze the relationship of changes in the urethral tissues with the composition of its microbiota, a PCR study of biopsies from the proximal segment of the urethra was performed in 13 patients with UPS. Results: Qualitative comparison of the thickness and character of the OCT signal of the urethral wall layers observed using CP OCT in the studied groups of patients allowed us to establish that the state of the epithelium and connective tissue structures of the mucous membrane in patients with UPS is not the norm, changes are similar to those in chronic inflammation. Changes in the character of the OCT signal were recorded in all parts of the urethra, but in the middle third they are most pronounced and most critical. In UPS, there is a brightly pronounced reorganization of the connective tissue stroma components. Pronounced fibrosis of subepithelial structures (increased signal brightness in the cross-channel compared to the norm) with their thickening was recorded in 48.2% of cases, and thinning/lack of visualization of the epithelial layer was detected in 20.5%, and in chronic inflammation 55.5% and 40.6% of cases, respectively. According to the results of PCR, only one patient had significant total bacterial contamination of the biopsy (ТВС=1047). In all other cases, the total bacterial mass of the biopsies was at the level of negative control. Conclusions. In patients with UPS, the presence of several concomitant, often chronic, diseases was revealed, which may be a premorbid background and one of the risk factors for the occurrence and maintenance of UPS. Pilot PCR studies of biopsies from the proximal segment of the urethra indicate that low values of bacterial contamination in the majority of patients with UPS do not exclude the possible role of bacteria in the development of the disease in some patients. The CP OCT method used in this study is currently the only one in vivo method of visualization of the urethral mucosa, which provides real-time images of structural changes in the epithelial (atrophy or hyperplasia) and connective tissue (active or latent inflammation with cellular infiltration or fibrosis) layers of the urethra, allowing better understanding of the pathogenesis of the disease and monitoring of therapy.

Full Text

Restricted Access

About the authors

O. S Streltsova

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: strelzova_uro@mail.ru
MD, Department of Urology n.a. E.V. Shakhova

M. N Boldyreva

National Research Centre «Institute of Immunology FMBA of Russia»

Email: m.n.boldyreva@mail.ru
MD, Immunogenetics Department of NSC Institute of Immunology

E. B Kiseleva

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: kiseleva84@gmail.com
PhD, Senior Researcher, Scientific Laboratory of Optical Coherence Tomography, Institute of Experimental Oncology and Biomedical Technologies.

M. A Molvi

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Email: msmolvi@mail.ru
postgraduate student of the Department of Urology. E.V. Shakhova

V. F Lazukin

Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation

Ph. D., associate Professor of the Department of medical physics and Informatics

References

  1. Engeler D., Baranowski A.P., Borovicka, Cottrell A.M., Dinis-Oliveira P., Elneil S., Hughes J., Messelink E.J., Williams A.C. de C. EAU guidelines on chronic pelvic pain. 2017. p. 52-374, https://uroweb.org/wp-content/ uploads/Chronic-pelvic-pain-2017-pocket.pdf
  2. Sung Tae Cho. Is Urethral Pain Syndrome Really Part of Bladder Pain Syndrome? Urogenital Tract Infection Urogenital Tract Infection, 2017;12(1):22-27. doi: 10.14777/uti.2017.12.1.22.
  3. Michael B. Rothberg, M.D., M.P.H., John B. Wong, M.D. All Dysuria Is Local A Cost-effectiveness Model for Designing Site-specific Management Algorithms. J. Gen Intern Med 2004;19:433-443.
  4. Fall M., Baranowski A.P., Elneil S., Engeler D., Hughes J., Messelink E.J., Oberpenning F., de C. Williams A.C. EAU Guideline on Chronic Pelvic Pain, Russian edition 2011: 64-102.
  5. Ю.Л. Набока, И.А. Гудима, С.В. Морданов, Д.В. Крахоткин, А.В. Ильяш, М.И. Коган, Д.В. Сизякин, Х.С. Ибишев. Вирусурия как составляющая микробиоты мочи и ее значение для оценки состояния здоровья мочевого тракта: описательное клиническое исследование Урология. 2020;1:12-18, Doi: https://dx.doi.org/10.18565/urology.2020.L12-18
  6. З.А. Кадыров, В.Н. Степанов, М.В. Фаниев, Ш.В. Рамишвили. Микробиота органов урогенитальной системы: обзор литературы. Урология. 2020; 1:116-120). Doi: https://dx.doi.org/10.18565/urology.2020.1.116-120
  7. Ford A.A., Veit-Rubin N. Cardozo L. Khullar V. Is the microbiome influencing patient care in lower urinary tract dysfunction? Report from the ICI-RS 2017. Neurourol Urodyn. 2018;37(S4): S93-S98. doi: 10.1002/nau.23708. Review.
  8. Nickel J.C. Prostatitis. Can Urol Assoc J. 20011;5(5):306-315.
  9. Осипов Г.А., Родионов Г.Г. Микроэкология человека в норме и патологии по данным масс-спектрометрии микробных маркеров. Медико-биологические и социально-психологические проблемы безопасности в чрезвычайных ситуациях. 2013;2:43-53
  10. О.С. Стрельцова, Е.Б. Киселева, М.А. Молви, В.Ф. Лазукин Структурные особенности уретры у больных с уретральным болевым синдромом. Экспериментальная и клиническая урология 2019;(3): 170-177, doi: 10.29188/2222-8543-2019-11-3-170-177
  11. Барулин А.Е., Курушина О.В., Думцев В.В., Мамина Р.М., Хроническая тазовая боль. Лекарственный вестник. 2016;1(61)10:35-41
  12. Зайцев А.В., Шаров М.Н., Пушкарь Д.Ю., Ходырева Л.А., Дударева А.А. Хроническая тазовая боль. Методические рекомендации № 20, М., 2016. С. 43
  13. Freund J.E., Buijs M., Savci-Heijink C.D., de Bruin D.M., de la Rosette J.J. M.C.H., van Leeuwen T.G., Laguna M.P. Optical Coherence Tomography in Urologic Oncology: a Comprehensive Review,” SN Comprehensive Clinical Medicine. 2019;1:6-84. Wang H.W., Chen Y., Clinical applications of optical coherence tomography in urology,” Intravital. 2014;3(1):e28770.
  14. Kiseleva E.B., Gubarkova E.V., Dudenkova V.V., Timashev P.S., Kotova S.L., Timofeeva L.B., Kirillin M.Yu., Belkova G.V., Solov’eva A.B., Streltsova O.S., Gladkova N.D., Complementary study of collagen state in bladder diseases using cross-polarization optical coherence tomography, nonlinear and atomic force microscopy. 2017;STM 9(1):7-18.
  15. Li W., Narice B.F., Anumba D.O., Matcher S.J., Polarization-sensitive optical coherence tomography with a conical beam scan for the investigation of birefringence and collagen alignment in the human cervix, Biomed. Opt. Express. 2019;10(8):4190-4206.
  16. Kiseleva E.B., Kirillin M.Yu., Feldchtein F.I., Vitkin I.A., Sergeeva E.A., Zagaynova E.V., Streltsova O.S., Shakhov B.E., Gubarkova E.V., Gladkova N.D. Differential diagnosis of human bladder mucosa pathologies in vivo with cross-polarization optical coherence tomography.” Biomed. Opt. Express. 2015;6(4):1464-1476.
  17. Dangle P.P., Shah K.K., Kaffenberger B., Patel V.R., The Use of High Resolution Optical Coherence Tomography to Evaluate Robotic Radical Prostatectomy Specimens. Int. Braz. J. Urol. 2009;35(3):344-353.
  18. Bus M.T., Muller B.G., de Bruin D.M., Faber D.J., Kamphuis G.M., van T.G. Leeuwen, T.M. de Reijke, de la Rosette J.J. Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study. J. Urol. 2013;190:2236-2242.
  19. Стрельцова О.С., Дуденкова В.В., Масленникова А.В., Киселева Е.Б., Тарарова Е.А., Юнусова К.Э., Синякова Л.А. Роль структурных изменений внеклеточного матрикса мочевого пузыря в возникновении побочных эффектов лучевой терапии разной степени тяжести. Урология. 2018;2:14-19. Doi: https://dx.doi.org/10.18565/urology.2018.214-19
  20. Дуденкова В.В., Масленникова А.В., Киселева Е.Б. и др. Количественная оценка радиационно-индуцированных изменений соединительнотканного матрикса мочевого пузыря методом нелинейной микроскопии. Современные технологии в медицине. 2018; 10(3): 118-124. Doi: 10.17691/ stm2018.10.3.14
  21. Kiseleva E.B., Gladkova N.D., Streltzova O.S., Kirillin M.Yu., Maslennikova A.V., Dudenkova V.V., Yunusova K.E. Sergeeva EA. Cross-polarization OCT for in vivo diagnostics and prediction of bladder cancer. Chapter 3. In: Bladder Cancer - Management of NMI and Muscle Invasive Cancer. Ed. by M. Ather. InTech. 2017;43-61:137. doi: 10.5772/63252.
  22. Streltzova O.S., Kiseleva E.B., Molvi M.A., Lazukin V.F. Cross-polarization OCT study of the urethra in patients with urethral pain syndrome. The VII International Symposium TOPICAL PROBLEMS OF BIOPHOTONICS-2019. Proceedings. 2019. P. 267-268.
  23. Киселева Е.Б., Молви М.А., Шилягин П.А., Ромашов В.Н., Юнусова К.Э., Геликонов Г.В. Стрельцова О.С. Возможности метода кросс-поляризационной оптической когерентной томографии в прижизненной оценке структурных изменений уретры при заболеваниях нижних мочевых путей. Сборник научных трудов VI съезда биофизиков России: том 2 - Краснодар: Полиграфическое объединение «Плехановец», 2019. С. 203
  24. Змушко ЕИ, Белозеров ЕС, Минин ЮА, Клиническая иммунология «Питер» Санкт-Петербург. 2001;574
  25. Воробьева А.А., Быкова А.С., Караулова А.В.. Иммунология и аллергология: учебное пособие для студентов медицинских вузов. Практическая медицина. 2006; 288 c
  26. Черкасов С.В. Бактериальные механизмы колонизационной резистентности репродуктивного тракта женщин. (Журнал микробиологии, эпидемиологии и иммунобиологии. 2006;4:100-105
  27. Набока Ю.Л., Гудима И.А., Джалагония К.Т., Черницкая М.Л., Иванов С.Н. Микобиота мочи и толстого кишечника у женщин с рецидивирующей неосложненной инфекцией нижних мочевых путей. Сборник материалов V итоговой научной сессии молодых ученых РОСТМГУ, 2018. С. 47-49
  28. Набока Ю.Л., Коган М.И., Гудима И.А., Митусова Е.В., Джалагония К.Т., Иванов С.Н. Существует ли взаимосвязь между микробиотой мочи, влагалища и кишечника при инфекции верхних мочевых путей? Вестник урологии. 2019;7(1):38-45. doi: 10.21886/2308-6424-2019-7 1-38-45

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies